Aurgalys Team
Selected Customers
Home
Interim Management
Quantum Genomics [ALQGC]
Corporate Finance
Management Assistance
Due Diligence
Interim Management
Investor Assistance
Onxeo [ONXEO]
Diaxonhit [ALEHT]
 

May 7th, 2015: Performance of French Life Sciences and Healthcare Smallcaps: 2 new IPOs on Alternext Paris

mai 07, 2015

Paris-Evry, France, May 7th, 2015 – Aurgalys, a global provider for life sciences and healthcare companies through corporate finance, business development and interim management services, issued its monthly publication of its indices measuring the performance of French, Life Sciences and Healthcare smallcaps.

Innate Pharma is the featured Biotech of the month, thanks to its $1.3 B deal with AstraZeneca to develop IPH2201 in the immuno-oncology field. The company almost doubled its market capitalization reaching €832 M as of April 30th, 2015. Also, the Alys France index welcomes two new biotech companies: Plant Advanced Technologies, producing active ingredients from plants, and Sensorion, specialized in inner ear disorders. The Alys France index gained 6.8% in April.

You can download our report on the following link:

 

Comments are closed.